Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Chambal Biotech Ltd
NSE: CHAMBALBIOBSE: 549886Pharma Formulations
₹603.25
▲ 13.05 (+2.21%)
Balance Sheet
- FY22: 14,037
- FY23: 15,735
- FY24: 17,768
- FY25: 20,156
- FY26: 22,907
- FY22: 2,029
- FY23: 2,188
- FY24: 4,741
- FY25: 3,840
- FY26: 5,962
- FY22: 20,754
- FY23: 25,528
- FY24: 28,080
- FY25: 30,247
- FY26: 35,989
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Share capital | 2,490 | 2,490 | 2,490 | 2,490 | 2,490 |
| Reserves | 11,547 | 13,245 | 15,278 | 17,666 | 20,417 |
| Total equity | 14,037 | 15,735 | 17,768 | 20,156 | 22,907 |
| Borrowings | 2,029 | 2,188 | 4,741 | 3,840 | 5,962 |
| Trade payables | 2,350 | 2,642 | 2,622 | 2,665 | 5,149 |
| Other current liabilities | 1,511 | 1,429 | 1,994 | 2,510 | 1,623 |
| Other liabilities | 827 | 3,535 | 955 | 1,076 | 348 |
| Total liabilities | 20,754 | 25,528 | 28,080 | 30,247 | 35,989 |
| Net block | 8,580 | 9,876 | 11,014 | 13,268 | 14,510 |
| Capital work in progress | 603 | 760 | 680 | 357 | 699 |
| Investments | 2,121 | 3,312 | 3,536 | 2,431 | 4,777 |
| Inventories | 3,642 | 4,399 | 3,903 | 5,480 | 6,066 |
| Trade receivables | 2,411 | 4,176 | 3,625 | 4,892 | 5,925 |
| Cash & equivalents | 2,661 | 3,205 | 1,749 | 2,401 | 4,415 |
| Other current assets | 737 | -200 | 3,574 | 1,417 | -403 |
| Total assets | 20,754 | 25,528 | 28,080 | 30,247 | 35,989 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 10 periods. Premium unlocks the full 10-year history. See Premium